Showing 1 - 4 results of 4 for search 'Péter Batár', query time: 0.02s Refine Results
  1. 1
    Treatment-Emergent Resistance to Asciminib in Chronic Myeloid Leukemia Patients Due to Myristoyl-Binding Pocket-Mutant of <i>BCR::ABL1/A337V</i> Can Be Effectively Overcome with Dasatinib Treatment

    Treatment-Emergent Resistance to Asciminib in Chronic Myeloid Leukemia Patients Due to Myristoyl-Binding Pocket-Mutant of <i>BCR::ABL1/A337V</i> Can Be Effectively Overcome with Da... by Peter Batar, Gabriella Mezei, Arpad Illes

    Published 2025-02-01
    Get full text
    Article
  2. 2
    Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from Hungary

    Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from Hungary by Peter Batar, Hussain Alizadeh, Gyorgy Rokszin, Zsolt Abonyi-Toth, Zsolt Abonyi-Toth, Judit Demeter

    Published 2024-02-01
    Get full text
    Article
  3. 3
    Corrigendum: Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from Hungary

    Corrigendum: Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from Hungar... by Peter Batar, Hussain Alizadeh, Gyorgy Rokszin, Zsolt Abonyi-Toth, Zsolt Abonyi-Toth, Judit Demeter

    Published 2024-03-01
    Get full text
    Article
  4. 4
    Dasatinib inhibits coated-platelet generation in patients with chronic myeloid leukemia

    Dasatinib inhibits coated-platelet generation in patients with chronic myeloid leukemia by Gabriella Mezei, Ildiko Beke Debreceni, Adrienne Kerenyi, Gyula Remenyi, Robert Szasz, Arpad Illes, Janos Kappelmayer, Peter Batar

    Published 2019-10-01
    Get full text
    Article

Search Tools: